Issue Behind Risperdal Lawsuits Considered as Medical Fraud

Legal reports have it have that a number of the filed lawsuits against Risperdal are due to the breast enlargement in men (gynecomastia). Before it became available as a generic medication in 2008, Risperdal was a best-seller drug. However, Johnson & Johnson (J&J) and its Janssen unit have faced wide legal problems over their Risperdal promotions. 

Furthermore, the issue of Risperdal is a considered a medical fraud because the drug was found to be misbranded or mislabeled and was indicated for unapproved uses. In addition, J&J was also discovered of paying kickbacks or extra fees to physicians, healthcare providers and the company named Omnicare Inc.

As a matter of fact, J&J has been scheduled for early trial dates, called “bellwether” cases. The detailed and full terms of these lawsuits have not been reported yet. Some lawsuits claims that J&J failed to thoroughly investigate on the effects of their medication and warn the consumers about the link between Risperdal and gynecomastia.

References:

healthcentral.com/schizophrenia/h/is-gynecomastia-from-risperdal-reversible.html

medscape.com/viewarticle/571416_6

ehealthme.com/ds/risperdal/gynecomastia